Intravenous Iron Drugs Global Market Report 2025

Intravenous Iron Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous iron drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for intravenous iron drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous iron drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product Type: Iron Dextran; Iron Sucrose; Ferric Carboxymaltose; Other Product Types

2) By Indication: Chronic Kidney Disease; Inflammatory Bowel Disease; Cancer; Other Diseases

3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

Subsegments:

1) By Iron Dextran: Low Molecular Weight Iron Dextran; High Molecular Weight Iron Dextran

2) By Iron Sucrose: Standard Iron Sucrose Injection; Iron Sucrose Complex

3) By Ferric Carboxymaltose: Single-Dose Ferric Carboxymaltose; Multiple-Dose Ferric Carboxymaltose

4) By Other Product Types: Ferumoxytol; Ferric Derisomaltose; Sodium Ferric Gluconate

Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Amgen Inc.; Fresenius SE & Co. KGaA; Teva Pharmaceutical Industries Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Intravenous Iron Drugs Market Characteristics
3. Intravenous Iron Drugs Market Trends And Strategies
4. Intravenous Iron Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Intravenous Iron Drugs Growth Analysis And Strategic Analysis Framework
5.1. Global Intravenous Iron Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Intravenous Iron Drugs Market Growth Rate Analysis
5.4. Global Intravenous Iron Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Intravenous Iron Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Intravenous Iron Drugs Total Addressable Market (TAM)
6. Intravenous Iron Drugs Market Segmentation
6.1. Global Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Iron Dextran
Iron Sucrose
Ferric Carboxymaltose
Other Product Types
6.2. Global Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Other Diseases
6.3. Global Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
6.4. Global Intravenous Iron Drugs Market, Sub-Segmentation Of Iron Dextran, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Low Molecular Weight Iron Dextran
High Molecular Weight Iron Dextran
6.5. Global Intravenous Iron Drugs Market, Sub-Segmentation Of Iron Sucrose, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Iron Sucrose Injection
Iron Sucrose Complex
6.6. Global Intravenous Iron Drugs Market, Sub-Segmentation Of Ferric Carboxymaltose, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Dose Ferric Carboxymaltose
Multiple-Dose Ferric Carboxymaltose
6.7. Global Intravenous Iron Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ferumoxytol
Ferric Derisomaltose
Sodium Ferric Gluconate
7. Intravenous Iron Drugs Market Regional And Country Analysis
7.1. Global Intravenous Iron Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Intravenous Iron Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Intravenous Iron Drugs Market
8.1. Asia-Pacific Intravenous Iron Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Intravenous Iron Drugs Market
9.1. China Intravenous Iron Drugs Market Overview
9.2. China Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Intravenous Iron Drugs Market
10.1. India Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Intravenous Iron Drugs Market
11.1. Japan Intravenous Iron Drugs Market Overview
11.2. Japan Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Intravenous Iron Drugs Market
12.1. Australia Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Intravenous Iron Drugs Market
13.1. Indonesia Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Intravenous Iron Drugs Market
14.1. South Korea Intravenous Iron Drugs Market Overview
14.2. South Korea Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Intravenous Iron Drugs Market
15.1. Western Europe Intravenous Iron Drugs Market Overview
15.2. Western Europe Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Intravenous Iron Drugs Market
16.1. UK Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Intravenous Iron Drugs Market
17.1. Germany Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Intravenous Iron Drugs Market
18.1. France Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Intravenous Iron Drugs Market
19.1. Italy Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Intravenous Iron Drugs Market
20.1. Spain Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Intravenous Iron Drugs Market
21.1. Eastern Europe Intravenous Iron Drugs Market Overview
21.2. Eastern Europe Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Intravenous Iron Drugs Market
22.1. Russia Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Intravenous Iron Drugs Market
23.1. North America Intravenous Iron Drugs Market Overview
23.2. North America Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Intravenous Iron Drugs Market
24.1. USA Intravenous Iron Drugs Market Overview
24.2. USA Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Intravenous Iron Drugs Market
25.1. Canada Intravenous Iron Drugs Market Overview
25.2. Canada Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Intravenous Iron Drugs Market
26.1. South America Intravenous Iron Drugs Market Overview
26.2. South America Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Intravenous Iron Drugs Market
27.1. Brazil Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Intravenous Iron Drugs Market
28.1. Middle East Intravenous Iron Drugs Market Overview
28.2. Middle East Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Intravenous Iron Drugs Market
29.1. Africa Intravenous Iron Drugs Market Overview
29.2. Africa Intravenous Iron Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Intravenous Iron Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Intravenous Iron Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Intravenous Iron Drugs Market Competitive Landscape And Company Profiles
30.1. Intravenous Iron Drugs Market Competitive Landscape
30.2. Intravenous Iron Drugs Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Intravenous Iron Drugs Market Other Major And Innovative Companies
31.1. CSL Limited
31.2. Sandoz Group AG.
31.3. Daiichi Sankyo Company Ltd.
31.4. Sun Pharmaceutical Industries Ltd.
31.5. Galenica Ltd.
31.6. Dr.Reddy's Laboratories
31.7. Hikma Pharmaceuticals plc
31.8. Zydus Lifesciences Limited
31.9. Biocon Limited
31.10. Kissei Pharmaceutical Co. Ltd.
31.11. American Regent Inc.
31.12. Akebia Therapeutics Inc.
31.13. Rockwell Medical Inc.
31.14. Pharmacosmos A/S
31.15. Shield Therapeutics plc
32. Global Intravenous Iron Drugs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Intravenous Iron Drugs Market
34. Recent Developments In The Intravenous Iron Drugs Market
35. Intravenous Iron Drugs Market High Potential Countries, Segments and Strategies
35.1 Intravenous Iron Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Intravenous Iron Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Intravenous Iron Drugs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings